Dual action of neutrophil gelatinase-associated lipocalin

Journal of the American Society of Nephrology

Volumn 18, Issue 2, 2007, Pages 407-413

  Schmidt Ott, Kai M ^a   Mori, Kiyoshi ^b   Jau, Yi Li ^a   Kalandadze, Avtandil ^a   Cohen, David J ^a   Devarajan, Prasad ^c   Barasch, Jonathan ^a  

^a College of Physicians and Surgeons ^*  (United States)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; IRON; IRON BINDING PROTEIN; LIPOCALIN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; SIDEROPHORE; UNCLASSIFIED DRUG;

ANIMAL CELL; BACTERIAL GROWTH; BACTERIOSTASIS; CELL DIFFERENTIATION; CELL GROWTH; CELL TYPE; EUKARYOTE; EXTRACELLULAR SPACE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INTRACELLULAR SPACE; IRON BINDING CAPACITY; IRON TRANSPORT; KIDNEY DEVELOPMENT; KIDNEY EPITHELIUM; KIDNEY INJURY; KIDNEY TUBULE CELL; KIDNEY TUBULE DAMAGE; LIVER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SECRETION; REVIEW; SYSTEMATIC REVIEW; UPREGULATION;

EID: 33846682720     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2006080882     Document Type: Review

References (40)

1. Flower DR: Experimentally determined lipocalin structures. Biochim Biophys Acta 1482: 46-56, 2000
2. Newcomer ME, Ong DE: Plasma retinol binding protein: Structure and function of the prototypic lipocalin. Biochim Biophys Acta 1482: 57-64, 2000
3. Larsson J, Allhorn M, Kerstrom B: The lipocalin alpha(1)-microglobulin binds heme in different species. Arch Biochem Biophys 432: 196-204, 2004
4. Weichsel A, Andersen JF, Champagne DE, Walker FA, Montfort WR: Crystal structures of a nitric oxide transport protein from a blood-sucking insect. Nat Struct Biol 5: 304-309, 1998
5. Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK: The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 10: 1033-1043, 2002
6. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A: Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432: 917-921, 2004
7. Berger T, Togawa A, Duncan GS, Elia AJ, You-Ten A, Wakeham A, Fong HE, Cheung CC, Mak TW: Lipocalin 2-deficient mice exhibit increased sensitivity to Escherichia coli infection but not to ischemia-reperfusion injury. Proc Natl Acad Sci U S A 103: 1834-1839, 2006
8. Schmidt-Ott KM, Mori K, Kalandadze A, Li JY, Paragas N, Nicholas T, Devarajan P, Barasch, J: Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia. Curr Opin Nephrol Hypertens 15: 442-449, 2006
9. Yang J, Goetz D, Li JY, Wang W, Mori K, Setlik D, Du T, Erdjument-Bromage H, Tempst P, Strong R, Barasch J: An iron delivery pathway mediated by a lipocalin. Mol Cell 10: 1045-1056, 2002
10. Challen GA, Martinez G, Davis MJ, Taylor DF, Crowe M, Teasdale RD, Grimmond SM, Little MH: Identifying the molecular phenotype of renal progenitor cells. J Am Soc Nephrol 15: 2344-2357, 2004
11. Yang J, Blum A, Novak T, Levinson R, Lai E, Barasch J: An epithelial precursor is regulated by the ureteric bud and by the renal stroma. Dev Biol 246: 296-310, 2002
12. Hanai J, Mammoto T, Seth P, Mori K, Karumanchi SA, Barasch J, Sukhatme VP: Lipocalin 2 diminishes invasiveness and metastasis of Ras-transformed cells. J Biol Chem 280: 13641-13647, 2005
13. Gwira JA, Wei F, Ishibe S, Ueland JM, Barasch J, Cantley LG: Expression of neutrophil gelatinase-associated lipocalin regulates epithelial morphogenesis in vitro. J Biol Chem 280: 7875-7882, 2005
14. Kamarainen M, Seppala M, Virtanen I, Andersson LC: Expression of glycodelin in MCF-7 breast cancer cells induces differentiation into organized acinar epithelium. Lab Invest 77: 565-573, 1997
15. Mallbris L, O'Brien KP, Hulthen A, Sandstedt B, Cowland JB, Borregaard N, Stahle-Backdahl M: Neutrophil gelatinase-associated lipocalin is a marker for dysregulated keratinocyte differentiation in human skin. Exp Dermatol 11: 584-591, 2002
16. Sorensen OE, Thapa DR, Roupe KM, Valore EV, Sjobring U, Roberts AA, Schmidtchen A, Ganz T: Injury-induced innate immune response in human skin mediated by transactivation of the epidermal growth factor receptor. J Clin Invest 116: 1878-1885, 2006
17. Ryon J, Bendickson L, Nilsen-Hamilton M: High expression in involuting reproductive tissues of uterocalin/24p3, a lipocalin and acute phase protein. Biochem J 367: 271-277, 2002
18. Bong JJ, Seol MB, Kim HH, Han O, Back K, Baik M: The 24p3 gene is induced during involution of the mammary gland and induces apoptosis of mammary epithelial cells. Mol Cells 17: 29-34, 2004
19. Liu Q, Ryon J, Nilsen-Hamilton M: Uterocalin: A mouse acute phase protein expressed in the uterus around birth. Mol Reprod Dev 46: 507-514, 1997
20. Devireddy LR, Gazin C, Zhu X, Green MR: A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake. Cell 123: 1293-1305, 2005
21. Hvidberg V, Jacobsen C, Strong RK, Cowland JB, Moestrup SK, Borregaard N: The endocytic receptor megalin binds the iron transporting neutrophil- gelatinase-associated lipocalin with high affinity and mediates its cellular uptake. FEBS Lett 579: 773-777, 2005
22. Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D'Agati V, Devarajan P, Barasch J: Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 115: 610-621, 2005
23. Leheste JR, Rolinski B, Vorum H, Hilpert J, Nykjaer A, Jacobsen C, Aucouturier P, Moskaug JO, Otto A, Christensen EI, Willnow TE: Megalin knockout mice as an animal model of low molecular weight proteinuria. Am J Pathol 155: 1361-1370, 1999
24. Gburek J, Verroust PJ, Willnow TE, Fyfe JC, Nowacki W, Jacobsen C, Moestrup SK, Christensen EI: Megalin and cubilin are endocytic receptors involved in renal clearance of hemoglobin. J Am Soc Nephrol 13: 423-430, 2002
25. Kozyraki R, Fyfe J, Verroust PJ, Jacobsen C, Dautry-Varsat A, Gburek J, Willnow TE, Christensen EI, Moestrup SK: Megalin-dependent cubilin-mediated endocytosis is a major pathway for the apical uptake of transferrin in polarized epithelia. Proc Natl Acad Sci U S A 98: 12491-12496, 2001
26. Li JY, Ram G, Gast K, Chen X, Barasch K, Mori K, Schmidt-Ott K, Wang J, Kuo HC, Savage-Dunn C, Garrick MD, Barasch J: Detection of intracellular iron by its regulatory effect. Am J Physiol Cell Physiol 287: C1547-C1559, 2004
27. Yang J, Mori K, Li JY, Barasch J: Iron, lipocalin, and kidney epithelia. Am J Physiol Renal Physiol 285: F9-F18, 2003
28. Fernandez-Pol JA: Isolation and characterization of a siderophore-like growth factor from mutants of SV40-transformed cells adapted to picolinic acid. Cell 14: 489-499, 1978
29. Jones RL, Peterson CM, Grady RW, Cerami A: Low molecular weight iron-binding factor from mammalian tissue that potentiates bacterial growth. J Exp Med 151: 418-428, 1980
30. Fjaertoft G, Foucard T, Xu S, Venge P: Human neutrophil lipocalin (HNL) as a diagnostic tool in children with acute infections: A study of the kinetics. Acta Paediatr 94: 661-666, 2005
31. Liu Q, Nilsen-Hamilton M: Identification of a new acute phase protein. J Biol Chem 270: 22565-22570, 1995
32. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P: Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14: 2534-2543, 2003
33. Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365: 1231-1238, 2005
34. Wagener G, Jan M, Kim M, Mori K, Barasch JM, Sladen RN, Lee HT: Association between increases in urinary neutrophil gelatinase-associated lipocalin and acute renal dysfunction after adult cardiac surgery. Anesthesiology 105: 485-491, 2006
35. Mishra J, Ma Q, Kelly C, Mitsnefes M, Mori K, Barasch J, Devarajan P: Kidney NGAL is a novel early marker of acute injury following transplantation. Pediatr Nephrol 21: 856-863, 2006
36. Mishra J, Mori K, Ma Q, Kelly C, Yang J, Mitsnefes M, Barasch J, Devarajan P: Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 15: 3073-3082, 2004
37. Bonventre JV, Sukhatme VP, Bamberger M, Ouellette AJ, Brown D: Localization of the protein product of the immediate early growth response gene, Egr-1, in the kidney after ischemia and reperfusion. Cell Regul 2: 251-260, 1991
38. Megyesi J, Di Mari J, Udvarhelyi N, Price PM, Safirstein R: DNA synthesis is dissociated from the immediate-early gene response in the post-ischemic kidney. Kidney Int 48: 1451-1458, 1995
39. Safirstein R, Megyesi J, Saggi SJ, Price PM, Poon M, Rollins BJ, Taubman MB: Expression of cytokine-like genes JE and KC is increased during renal ischemia. Am J Physiol 261: F1095-F1101, 1991
40. Witzgall R, Brown D, Schwarz C, Bonventre JV: Localization of proliferating cell nuclear antigen, vimentin, c-Fos, and clusterin in the postischemic kidney. Evidence for a heterogenous genetic response among nephron segments, and a large pool of mitotically active and dedifferentiated cells. J Clin Invest 93: 2175-2188, 1994